Cagrilintide in Vietnam
Cagrilintide is a peptide research compound. The current listed format is a 5 mg vial.
Strengths & prices
| Vial strength | Price | Listed status | Inquiry |
|---|---|---|---|
| 5 mg | 750,000 ₫ US$30 | In stock | Ask about this strength |
Batch certificates
Independent lab reports for each listed strength. Match the batch number on your vial label to the report.
About Cagrilintide
Cagrilintide is a long-acting analogue of amylin, a hormone released by the pancreas together with insulin. It was developed by Novo Nordisk and has been studied mainly in combination with semaglutide, a product known as CagriSema.
Novo Nordisk filed CagriSema for FDA review in December 2025. Cagrilintide on its own is not an approved medicine. PepsVN supplies it for laboratory research only.
What PepsVN supplies
- Form Lyophilised (freeze-dried) powder in a sealed glass vial.
- Strength 5 mg per vial.
- Documentation An independent batch certificate is linked above.
- Delivery Free same-day delivery in Da Nang. Free overnight delivery to Ho Chi Minh City and Hanoi on orders over 1,500,000₫, and free 2–4 day shipping everywhere else in Vietnam (delivery details).
How to read the batch certificate
Each certificate describes one tested batch, not every vial ever produced. When your order arrives, check three things against the certificate:
- Batch number The number on your vial label should match the batch number on the report (for example, CAG508C).
- Reported quantity The measured amount in the tested vial, compared with the labelled strength.
- Reported purity The percentage of the sample identified as Cagrilintide in the lab's testing.
The "Verify report" button on each certificate opens the testing lab's own record, so you can confirm the report is genuine rather than relying on a copy.
Storage and handling
Keep unopened vials in the refrigerator (2–8 °C), away from light. Freeze-dried peptides tolerate room temperature for short periods, such as a few days in transit. Long-term exposure to Vietnam's heat and humidity should still be avoided. Once reconstituted, a peptide is far less stable, so it should be kept refrigerated and used within the period given in your research protocol. See our storage guide for more detail.
Common questions
Is Cagrilintide an approved medicine?
No. Cagrilintide is not approved as a standalone medicine. It has been studied mainly as part of the CagriSema combination, which Novo Nordisk submitted for FDA review in December 2025.
How is cagrilintide different from GLP-1 compounds?
Cagrilintide acts on amylin receptors, whereas compounds such as semaglutide act on GLP-1 receptors. Tirzepatide and retatrutide act on GLP-1 plus other receptors, but not on amylin receptors.
What exactly is in the 5 mg vial?
The label states 5 mg. The linked certificate for batch CAG508C reported 5.02 mg with a purity of 99.79%. Your vial should carry a matching batch number, or we will share the report for the batch you receive.
Can I see the certificate for my exact batch?
Yes. Send us the strength you are ordering and we will confirm which batch you will receive and share its report before you pay.
Ordering & delivery
Send the product, strength, quantity and your city. PepsVN will confirm stock, the supplied batch, delivery timing and total cost.
Research information & handling
Use the product label and batch-specific documentation for identification and handling. A certificate describes the tested sample; it does not establish suitability for human or animal use.
Confirm stock for Cagrilintide
Tell us the strength, quantity and delivery city. We reply with availability, the batch you will receive and the total cost.